How Axsome Therapeutics makes money

Period

FY2025

How does Axsome Therapeutics make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Axsome Therapeutics Inc. · FY2025 · year ended 2025-12-31

Revenue$638MNet loss$183M · 29%Cost of revenue$0 · 0%Gross profit$638M · 100%Operating expenses$805M · 126%R&D$183M · 29%SG&A$571M · 89%Other opex$51M · 8%Other expense$16M · 3%Product$634M · 99%Royalty & Milestone Revenue$5M · 1%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.